Elite Pharmaceuticals Inc (ELTP)

[vanwes1]

My point once again. Nasarat knew there was an issue with the pharmacokinetics of the drug. This would likely have been talked about if he had put the data out there. All we got the last 2 years is "no one will stop us." Oh and cant forget the snippet that Couch kept giving us about significance of the phase 3 trial based on the p value. The CEO has not been truthful about the obstacles that he knew about prior to submission. He never let shareholders know, nor did he try to get it right prior to submission. You cant sneak things past the FDA. He knew the study was flawed and decided not to do what was in the best interest of the investor which is to be honest about the data.

NASA"RAT" THE CLOSER. LOL